Vericel Corp
VCEL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000887359
In the last 90 days, Vericel Corp insiders filed 0 open-market purchases and 3 sales; 320 institutions reported holding it in 13F filings for Q2 2026, worth $2.47B in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Vericel Corp changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 200 | 202 | +2 |
| Shares | 50.4M | 50.0M | −333.3K (−0.7%) |
| Value | $1.48B | $1.88B | +$401.3M (+27.2%) |
New holders (29)
Institutions that held Vericel Corp at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (27)
Institutions that held Vericel Corp at the end of Q1 2023 and filed for Q2 2023 without it.